{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T19:39:53Z","timestamp":1790278793061,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jaacap.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jaac.2018.01.015","type":"journal-article","created":{"date-parts":[[2018,2,7]],"date-time":"2018-02-07T22:43:19Z","timestamp":1518043399000},"page":"235-244.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A\u00a0Meta-Analysis"],"prefix":"10.1016","volume":"57","author":[{"given":"Jeffrey R.","family":"Strawn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau A.","family":"Sauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Welge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaac.2018.01.015_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/DBP.0000000000000296","article-title":"Association of childhood anxiety disorders and quality of life in a primary care sample","volume":"37","author":"Ramsawh","year":"2016","journal-title":"J\u00a0Dev Behav Pediatr"},{"key":"10.1016\/j.jaac.2018.01.015_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/acps.12792","article-title":"Sociodemographic, clinical, and functional long-term outcomes in adolescents and young adults with mental disorders","volume":"137","author":"Asselmann","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jaac.2018.01.015_bib3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archpsyc.64.8.903","article-title":"Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life","volume":"64","author":"Beesdo","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/archpsyc.55.1.56","article-title":"The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders","volume":"55","author":"Pine","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2215-0366(15)00092-9","article-title":"Secondary depression in severe anxiety disorders: a population-based cohort study in Denmark","volume":"2","author":"Meier","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.chc.2012.05.001","article-title":"Developmental epidemiology of anxiety disorders","volume":"21","author":"Beesdo-Baum","year":"2012","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2018.01.015_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1176\/appi.ps.201200058","article-title":"Twelve-month suicidal symptoms and use of services among adolescents: results from the National Comorbidity Survey","volume":"63","author":"Husky","year":"2012","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.jaac.2018.01.015_bib8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/jamapsychiatry.2017.2432","article-title":"Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis","volume":"74","author":"Locher","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jamapediatrics.2017.3036","article-title":"Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: a systematic review and meta-analysis","volume":"171","author":"Wang","year":"2017","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaac.2018.01.015_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/da.22329","article-title":"Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis","volume":"32","author":"Strawn","year":"2015","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jaac.2018.01.015_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/ajp.2007.164.2.290","article-title":"Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials","volume":"164","author":"Rynn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib12","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1176\/appi.ajp.158.12.2008","article-title":"Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder","volume":"158","author":"Rynn","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.biopsych.2007.02.025","article-title":"A\u00a0randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder","volume":"62","author":"March","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib14","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200104263441703","article-title":"Fluvoxamine for the treatment of anxiety disorders in children and adolescents","volume":"344","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2018.01.015_bib15","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2018.01.015_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaac.2015.01.008","article-title":"A\u00a0randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder","volume":"54","author":"Strawn","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","article-title":"Fluoxetine for the treatment of childhood anxiety disorders","volume":"42","author":"Birmaher","year":"2003","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib18","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archpsyc.61.11.1153","article-title":"A\u00a0multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder","volume":"61","author":"Wagner","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1176\/appi.ajp.2015.15030331","article-title":"Systematic review and meta-analysis: dose-response relationship of selective serotonin reuptake inhibitors in major depressive disorder","volume":"173","author":"Jakubovski","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib20","doi-asserted-by":"crossref","first-page":"e605","DOI":"10.4088\/JCP.14r09758","article-title":"Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis","volume":"77","author":"Issaria","year":"2016","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib21","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaac.2016.07.768","article-title":"Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors and clomipramine in pediatric obsessive-compulsive disorder","volume":"55","author":"Varigonda","year":"2016","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jaac.2015.05.004","article-title":"Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors in pediatric major depressive disorder","volume":"54","author":"Varigonda","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib24","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.2014.13101337","article-title":"Treatment of separation, generalized, and social anxiety disorders in youths","volume":"171","author":"Mohatt","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.chi.0000246070.23695.06","article-title":"Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders","volume":"46","author":"Connolly","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib26","first-page":"1263","article-title":"Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis","author":"Cipriani","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaac.2018.01.015_bib27","doi-asserted-by":"crossref","first-page":"e016608","DOI":"10.1136\/bmjopen-2017-016608","article-title":"Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis","volume":"7","author":"Zhou","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaac.2018.01.015_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/wps.20038","article-title":"The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons","volume":"12","author":"Cuijpers","year":"2013","journal-title":"World Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00004583-200209000-00006","article-title":"The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties","volume":"41","author":"RUPP","year":"2002","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.jaac.2018.01.015_bib31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0005-7967(98)00034-5","article-title":"A\u00a0measure of anxiety symptoms among children","volume":"36","author":"Spence","year":"1998","journal-title":"Behav Res Ther"},{"key":"10.1016\/j.jaac.2018.01.015_bib32","doi-asserted-by":"crossref","first-page":"e010919","DOI":"10.1136\/bmjopen-2015-010919","article-title":"Comparative efficacy and acceptability of first-generation and second-generation antidepressants in the acute treatment of major depression: protocol for a network meta-analysis","volume":"6","author":"Furukawa","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaac.2018.01.015_bib33","first-page":"3","article-title":"Cochrane Handbook: Cochrane Reviews: Ch 8: Assessing risk of bias in included studies","volume":"6","author":"Higgins","year":"2011"},{"key":"10.1016\/j.jaac.2018.01.015_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/07474939208800232","article-title":"A\u00a0comparison of model selection criteria","volume":"11","author":"Mills","year":"1992","journal-title":"Econom Rev"},{"key":"10.1016\/j.jaac.2018.01.015_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/cap.2017.0060","article-title":"Buspirone in children and adolescents with anxiety: a review and Bayesian analysis of abandoned randomized controlled trials","volume":"28","author":"Strawn","year":"2018","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2018.01.015_bib36","doi-asserted-by":"crossref","unstructured":"Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. Boca Raton, FL: CRC Press; 2014\/","DOI":"10.1201\/b16018"},{"key":"10.1016\/j.jaac.2018.01.015_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuroimage.2013.08.001","article-title":"Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: implications on treatment of depression and ADHD","volume":"86","author":"Ding","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.jaac.2018.01.015_bib38","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/j.1476-5381.2009.00478.x","article-title":"Differential inhibitory effects of drugs acting at the noradrenaline and 5-hydroxytryptamine transporters in rat and human neocortical synaptosomes","volume":"158","author":"Mantovani","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaac.2018.01.015_bib39","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1137\/141000671","article-title":"Julia: a fresh approach to numerical computing","volume":"59","author":"Bezanson","year":"2017","journal-title":"SIAM Rev"},{"key":"10.1016\/j.jaac.2018.01.015_bib40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaac.2018.01.015_bib41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/chi.0b013e3180ca8385","article-title":"Atomoxetine treatment for pediatric patients with attention-deficit\/hyperactivity disorder with comorbid anxiety disorder","volume":"46","author":"Geller","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib42","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1176\/appi.ajp.2008.08070976","article-title":"Predictors of spontaneous and systematically assessed suicidal adverse events in the Treatment of SSRI-Resistant Depression in Adolescents (TORDIA) study","volume":"166","author":"Brent","year":"2009","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib43","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.bcp.2007.01.028","article-title":"Comparison of the maturation of the adrenergic and serotonergic neurotransmitter systems in the brain: implications for differential drug effects on juveniles and adults","volume":"73","author":"Murrin","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"Suppl1","key":"10.1016\/j.jaac.2018.01.015_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jaac.2018.01.015_bib45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/11591660-000000000-00000","article-title":"Antidepressants and psychostimulants in pediatric populations: is there an association with mania?","volume":"13","author":"Goldsmith","year":"2011","journal-title":"Pediatr Drugs"},{"key":"10.1016\/j.jaac.2018.01.015_bib46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/bdi.12113","article-title":"Antidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study","volume":"16","author":"Strawn","year":"2013","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.jaac.2018.01.015_bib47","first-page":"1","article-title":"Antidepressant efficacy for depression in children and adolescents: industry- and NIMH-funded studies","author":"Walkup","year":"2017","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib48","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.chc.2012.05.003","article-title":"Psychopharmacologic treatment of children and adolescents with anxiety disorders","volume":"21","author":"Strawn","year":"2012","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2018.01.015_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11920-015-0591-z","article-title":"Assessment and treatment of anxiety disorders in children and adolescents","volume":"17","author":"Wehry","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.jaac.2018.01.015_bib50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpsychires.2015.10.006","article-title":"Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial","volume":"71","author":"Reid","year":"2015","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jaac.2018.01.015_bib51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/JCP.0b013e318204b117","article-title":"Antidepressant exposure as a predictor of clinical outcomes in the Treatment of Resistant Depression in Adolescents (TORDIA) study","volume":"31","author":"Sakolsky","year":"2011","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jaac.2018.01.015_bib52","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/sj.npp.1300960","article-title":"Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder","volume":"31","author":"Findling","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jaac.2018.01.015_bib53","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/cap.2006.16.131","article-title":"The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression","volume":"16","author":"Findling","year":"2006","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2018.01.015_bib54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jaac.2014.12.015","article-title":"Child\/Adolescent Anxiety Multimodal Study: evaluating safety","volume":"54","author":"Rynn","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1089\/cap.2008.040","article-title":"Activation adverse events induced by the selective serotonin reuptake inhibitor fluvoxamine in children and adolescents","volume":"19","author":"Reinblatt","year":"2009","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2018.01.015_bib56","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology\u2014drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2018.01.015_bib57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1089\/cap.2016.0155","article-title":"Pharmacokinetics and safety of vortioxetine in pediatric patients","volume":"27","author":"Findling","year":"2017","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2018.01.015_bib58","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1089\/cap.2013.0096","article-title":"A\u00a0double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder","volume":"24","author":"Emslie","year":"2014","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2018.01.015_bib59","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.2044-8317.2012.02063.x","article-title":"Posterior predictive checks can and should be Bayesian: comment on Gelman and Shalizi, \u201cPhilosophy and the practice of Bayesian statistics.\u201d","volume":"66","author":"Kruschke","year":"2013","journal-title":"Br J Math Stat Psychol"},{"key":"10.1016\/j.jaac.2018.01.015_bib60","series-title":"Bayesian Nets and Causality: Philosophical and Computational Foundations","author":"Williamson","year":"2005"},{"key":"10.1016\/j.jaac.2018.01.015_bib61","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1089\/cap.2015.0192","article-title":"Placebo response in pediatric anxiety disorders: implications for clinical trial design and interpretation","volume":"26","author":"Dobson","year":"2016","journal-title":"J\u00a0Child Adolesc Psychopharmocology"},{"key":"10.1016\/j.jaac.2018.01.015_bib62","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s11222-013-9416-2","article-title":"Understanding predictive information criteria for Bayesian models","volume":"24","author":"Gelman","year":"2014","journal-title":"Stat Comput"},{"key":"10.1016\/j.jaac.2018.01.015_bib63","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/cap.2016.0198","article-title":"Placebo response in pediatric anxiety disorders: results from the child\/adolescent anxiety multimodal study","volume":"27","author":"Strawn","year":"2017","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2018.01.015_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1753-2000-4-1","article-title":"Child\/Adolescent Anxiety Multimodal Study (CAMS): rationale, design, and methods","volume":"4","author":"Compton","year":"2010","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"10.1016\/j.jaac.2018.01.015_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/cap.2016.0132","article-title":"Extended release guanfacine in pediatric anxiety disorders: a pilot, randomized, placebo-controlled trial","volume":"27","author":"Strawn","year":"2017","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2018.01.015_bib66","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.janxdis.2010.01.009","article-title":"Clinical characteristics of anxiety disordered youth","volume":"24","author":"Kendall","year":"2010","journal-title":"J\u00a0Anxiety Disord"},{"key":"10.1016\/j.jaac.2018.01.015_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.chc.2012.05.002","article-title":"Neural substrates of childhood anxiety disorders: a review\u00a0of neuroimaging findings","volume":"21","author":"Blackford","year":"2012","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/j.jaac.2018.01.015_bib68","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s40473-014-0014-1","article-title":"Neurobiology of pediatric anxiety disorders","volume":"1","author":"Strawn","year":"2014","journal-title":"Curr Behav Neurosci Reports"},{"key":"10.1016\/j.jaac.2018.01.015_bib69","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJMsr1203730","article-title":"The prevention and treatment of missing data in clinical trials","volume":"367","author":"Little","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2018.01.015_bib71","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1176\/appi.ajp.158.12.2008","article-title":"Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder","volume":"158","author":"Rynn","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib72","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJM200104263441703","article-title":"Fluvoxamine for the treatment of anxiety disorders in children and adolescents","volume":"344","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2018.01.015_bib73","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/01.CHI.0000037049.04952.9F","article-title":"Fluoxetine for the treatment of childhood anxiety disorders","volume":"42","author":"Birmaher","year":"2003","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib74","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/archpsyc.61.11.1153","article-title":"A\u00a0multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder","volume":"61","author":"Wagner","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib75","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1097\/chi.0b013e3180ca8385","article-title":"Atomoxetine treatment for pediatric patients with attention-deficit\/hyperactivity disorder with comorbid anxiety disorder","volume":"46","author":"Geller","year":"2007","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib76","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.biopsych.2007.02.025","article-title":"A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder","volume":"62","author":"March","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib77","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/ajp.2007.164.2.290","article-title":"Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials","volume":"164","author":"Rynn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jaac.2018.01.015_bib78","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1056\/NEJMoa0804633","article-title":"Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety","volume":"359","author":"Walkup","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaac.2018.01.015_bib79","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaac.2015.01.008","article-title":"A\u00a0randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder","volume":"54","author":"Strawn","year":"2015","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"}],"container-title":["Journal of the American Academy of Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856718300534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856718300534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T18:02:59Z","timestamp":1603821779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856718300534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0890856718300534"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2018.01.015","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732936277.793554658","asserted-by":"object"}]},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Impact of Antidepressant Dose and Class on Treatment Response in Pediatric Anxiety Disorders: A\u00a0Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2018.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92018 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}